Skip to content

Effect of intraoperative tourniquet and perioperative dexamethasone on pain and inflammatory response after total knee arthroplasty: a prospective randomized controlled study

Effect of intraoperative tourniquet and perioperative dexamethasone on pain and inflammatory response after total knee arthroplasty: a prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098853
Enrollment
Unknown
Registered
2025-03-14
Start date
2024-10-14
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

A:No intervention
B:tourniquet
C:tourniquet and low dose dexamethasone
D:tourniquet and high dose dexamethasone

Sponsors

West Chian Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with primary or secondary osteoarthritis of the terminal knee joint on one side who are scheduled to undergo total knee arthroplasty in the Department of Orthopedics and Joint Surgery of our hospital for the first time; (2) aged 18 to 80; (3) patients who voluntarily participate in clinical trials and sign informed consent forms and have good compliance.

Exclusion criteria

Exclusion criteria: (1) Elevated inflammatory indicators before surgery: CRP >10mg/L, IL-6>15pg/L; (2) Preoperative hemoglobin level 15°, varus deformity>15°, valgus deformity>15°; (4) autoimmune and metabolic knee arthritis, such as rheumatoid arthritis and gouty arthritis; (5) people who have been taking hormones for a long time due to autoimmune diseases and kidney disease, and patients with hypercortisolism; (6) patients with diabetes whose blood sugar is difficult to control and patients with previous gastrointestinal bleeding and perforation; (7) patients who the investigator believes are not suitable to participate in this clinical trial

Design outcomes

Primary

MeasureTime frame
visual analogue scale;Inflammation markers;Cumulative morphine use;blood loss;

Secondary

MeasureTime frame
Hospital for Special Surgery knee score;Knee range of motion and circumference;myometry;Imaging to assess muscle volume;Intraoperative stress assessment for anaesthetists;Difficulty of anaesthesia and anaesthetic risk assessment;

Countries

China

Contacts

Public ContactQiang Huang

West China Hospital,Sichuan University

huangqiang4325@126.com+86 189 8060 6708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026